157 related articles for article (PubMed ID: 35434798)
1. Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemia.
Meyer LK; Delgado-Martin C; Sharp PP; Huang BJ; McMinn D; Vincent TL; Ryan T; Horton TM; Wood BL; Teachey DT; Taunton J; Kirk CJ; Hermiston ML
Br J Haematol; 2022 Jul; 198(1):137-141. PubMed ID: 35434798
[TBL] [Abstract][Full Text] [Related]
2. DT7 peptide-modified lecithin nanoparticles co-loaded with γ-secretase inhibitor and dexamethasone efficiently inhibit T-cell acute lymphoblastic leukemia and reduce gastrointestinal toxicity.
Zhou Y; Guan L; Li W; Jia R; Jia L; Zhang Y; Wen X; Meng S; Ma D; Zhang N; Ji M; Liu Y; Ji C
Cancer Lett; 2022 May; 533():215608. PubMed ID: 35240234
[TBL] [Abstract][Full Text] [Related]
3. JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias.
Delgado-Martin C; Meyer LK; Huang BJ; Shimano KA; Zinter MS; Nguyen JV; Smith GA; Taunton J; Winter SS; Roderick JR; Kelliher MA; Horton TM; Wood BL; Teachey DT; Hermiston ML
Leukemia; 2017 Dec; 31(12):2568-2576. PubMed ID: 28484265
[TBL] [Abstract][Full Text] [Related]
4. Effect of hypoxia on proliferation and glucocorticoid resistance of T-cell acute lymphoblastic leukaemia.
Li Y; Wei Y; Gu L
Hematology; 2021 Dec; 26(1):775-784. PubMed ID: 34565306
[TBL] [Abstract][Full Text] [Related]
5. Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK.
Liu Y; Ge J; Li Q; Guo X; Gu L; Ma ZG; Li XH; Zhu YP
Leuk Lymphoma; 2014 Sep; 55(9):2179-88. PubMed ID: 24597985
[TBL] [Abstract][Full Text] [Related]
6. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
[TBL] [Abstract][Full Text] [Related]
7. LRH-1/NR5A2 interacts with the glucocorticoid receptor to regulate glucocorticoid resistance.
Michalek S; Goj T; Plazzo AP; Marovca B; Bornhauser B; Brunner T
EMBO Rep; 2022 Sep; 23(9):e54195. PubMed ID: 35801407
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes.
Meyer LK; Huang BJ; Delgado-Martin C; Roy RP; Hechmer A; Wandler AM; Vincent TL; Fortina P; Olshen AB; Wood BL; Horton TM; Shannon KM; Teachey DT; Hermiston ML
J Clin Invest; 2020 Feb; 130(2):863-876. PubMed ID: 31687977
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism.
Beesley AH; Firth MJ; Ford J; Weller RE; Freitas JR; Perera KU; Kees UR
Br J Cancer; 2009 Jun; 100(12):1926-36. PubMed ID: 19436302
[TBL] [Abstract][Full Text] [Related]
10. Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALL.
Levinson AL; Tjoa K; Huang B; Meyer LK; Kim MO; Brady SW; Zhang J; Shannon K; Wandler AM
Blood Adv; 2023 Jul; 7(14):3479-3484. PubMed ID: 36897249
[TBL] [Abstract][Full Text] [Related]
11. Bioenergetic modulation overcomes glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia.
Samuels AL; Heng JY; Beesley AH; Kees UR
Br J Haematol; 2014 Apr; 165(1):57-66. PubMed ID: 24456076
[TBL] [Abstract][Full Text] [Related]
12. Functions and Mechanisms of the Human Ribosome-Translocon Complex.
Lang S; Nguyen D; Pfeffer S; Förster F; Helms V; Zimmermann R
Subcell Biochem; 2019; 93():83-141. PubMed ID: 31939150
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
[TBL] [Abstract][Full Text] [Related]
14. The p27-Skp2 axis mediates glucocorticoid-induced cell cycle arrest in T-lymphoma cells.
Kullmann MK; Grubbauer C; Goetsch K; Jäkel H; Podmirseg SR; Trockenbacher A; Ploner C; Cato AC; Weiss C; Kofler R; Hengst L
Cell Cycle; 2013 Aug; 12(16):2625-35. PubMed ID: 23907123
[TBL] [Abstract][Full Text] [Related]
15. Endoplasmic reticulum stress, unfolded protein response and autophagy contribute to resistance to glucocorticoid treatment in human acute lymphoblastic leukaemia cells.
Sudsaward S; Khunchai S; Thepmalee C; Othman A; Limjindaporn T; Yenchitsomanus PT; Mutti L; Krstic-Demonacos M; Demonacos C
Int J Oncol; 2020 Sep; 57(3):835-844. PubMed ID: 32705154
[TBL] [Abstract][Full Text] [Related]
16. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
He L; Li D; Hou KZ; Liu YP
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
[TBL] [Abstract][Full Text] [Related]
17. Synergistic inhibitory activities of interleukin-10 and dexamethasone on human CD4+ T cells.
Brunetti M; Mascetra N; Martelli N; Ranelletti FO; Musiani P; Aiello FB
Transplantation; 2002 Oct; 74(8):1152-8. PubMed ID: 12438963
[TBL] [Abstract][Full Text] [Related]
18. Notch1 and IL-7 receptor signalling in early T-cell development and leukaemia.
González-García S; García-Peydró M; Alcain J; Toribio ML
Curr Top Microbiol Immunol; 2012; 360():47-73. PubMed ID: 22695916
[TBL] [Abstract][Full Text] [Related]
19. Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia.
Shi Y; Beckett MC; Blair HJ; Tirtakusuma R; Nakjang S; Enshaei A; Halsey C; Vormoor J; Heidenreich O; Krippner-Heidenreich A; van Delft FW
Haematologica; 2021 Apr; 106(4):1056-1066. PubMed ID: 32139432
[TBL] [Abstract][Full Text] [Related]
20. Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia.
Wandler AM; Huang BJ; Craig JW; Hayes K; Yan H; Meyer LK; Scacchetti A; Monsalve G; Dail M; Li Q; Wong JC; Weinberg O; Hasserjian RP; Kogan SC; Jonsson P; Yamamoto K; Sampath D; Nakitandwe J; Downing JR; Zhang J; Aster JC; Taylor BS; Shannon K
Leukemia; 2020 Aug; 34(8):2025-2037. PubMed ID: 32066867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
